All remdesivir articles
-
News
Oral nucleoside antiviral is progressing toward future pandemic preparedness
Oral obeldesivir has been shown to reduce disease severity in mice infected with one of several different coronaviruses, including SARS-CoV-2 (which causes COVID-19), SARS-CoV and MERS-CoV.
-
News
WHO updates its guidance on treatments for COVID-19
The new recommendations reflect the evolving nature of the virus and the changing role of Covid-19 therapies.